Business
ArsenalBio sheds most of staff in pivot to in vivo CAR-T - Fierce Biotech

What the report says
About a year after halving its staff in a clinical push, Arsenal Biosciences is now making a
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Uganda’s informal economy seeks strength in numbersThe Observer
Gen. Saleh Calls For Review Of Caged-Fishing And Coffee-Farming ProjectsWatchdog Uganda
Rubanda Launches Shs40m Road Project to Boost Farm-to-Market AccessNile Post